Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FR.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCMNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HN.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.42.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HN.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.7.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.20.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.5.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.13.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JY.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCRNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.86NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GJ.1.2.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GE.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HN.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.11.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.3.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GL.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.8.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.3.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.6.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GW.5.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KC.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.3.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.5.5.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.503NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.623NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.214.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.588NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20190.6US
B.1.210NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.567NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.541NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-18513.9US
B.1.189NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.563NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.34NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.258NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used